Patient Care

PROCEPT BioRobotics® Receives U.S. FDA Investigational Device Exemption to Investigate Aquablation® Therapy for Prostate Cancer

REDWOOD CITY, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics”), a global leader in...

AdhereHealth CEO to Lead the University of Tennessee Health Science Center’s Discussions on Medication Adherence and Achieving the Quintuple Aim of Healthcare

Series of virtual events hosted by UTHSC's College of Pharmacy will educate hundreds of pharmacists throughout the U.S. on the...

error: Content is protected !!